Centessa Pharmaceuticals plc
Industry: Life Sciences ・ $CNTA on Nasdaq
Insider Sale
+$909,150
-6.75%
Shares
Shares Volume: 55,000 Shares
Average Share Price: $16.53
INSIDER
SAHA SAURABH
Chief Executive Officer (Director)
reported on Sep 20 2024
traded on Sep 20 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 759,924 |
| PURCHASES/SALES 1Y | 0 / 4 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $1,119,099.88 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
| PURCHASES/SALES 1Y | 0 / 10 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $660,897.54 |
| COMPANY PREVIOUS TRADES |